FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048587704> ?p ?o ?g. }

• W3048587704 endingPage "775" @default.
• W3048587704 startingPage "759" @default.
• W3048587704 abstract "Breast cancer affects women globally; the majority of breast cancer-related mortalities are due to metastasis. Acquisition of a mesenchymal phenotype has been implicated in the progression of breast cancer cells to an invasive, metastatic state. Triple-negative breast cancer (TNBC) subtypes have high rates of metastases, recurrence, and have poorer prognoses compared to other breast cancer types, partially due to lack of commonly targeted receptors. Kinases have diverse and pivotal functions in metastasis in TNBC, and discovery of new kinase targets for TNBC is warranted. We previously used a screening approach to identify intermediate-synthesis nonpotent, nonselective small-molecule inhibitors from the Published Kinase Inhibitor Set that reversed the mesenchymal phenotype in TNBC cells. Two of these inhibitors (GSK346294A and GSK448459A) are structurally similar, but have unique kinase activity profiles and exhibited differential biologic effects on TNBC cells, specifically on epithelial-to-mesenchymal transition (EMT). Here, we further interrogate these effects and compare activity of these inhibitors on transwell migration, gene (qRT-PCR) and protein (western blot) expressions, and cancer stem cell-like behavior. We incorporated translational patient-derived xenograft models in these studies, and we focused on the lead inhibitor hit, GSK346294A, to demonstrate the utility of our comparative analysis as a screening modality to identify novel kinase targets and signaling pathways to pursue in TNBC. This study introduces a new method for discovering novel kinase targets that reverse the EMT phenotype; this screening approach can be applied to all cancer types and is not limited to breast cancer." @default.
• W3048587704 created "2020-08-18" @default.
• W3048587704 creator A5006697336 @default.
• W3048587704 creator A5010254355 @default.
• W3048587704 creator A5010293836 @default.
• W3048587704 creator A5017494236 @default.
• W3048587704 creator A5017610194 @default.
• W3048587704 creator A5029131894 @default.
• W3048587704 creator A5030154591 @default.
• W3048587704 creator A5030449403 @default.
• W3048587704 creator A5034349178 @default.
• W3048587704 creator A5038821469 @default.
• W3048587704 creator A5040817295 @default.
• W3048587704 creator A5041222618 @default.
• W3048587704 creator A5041301571 @default.
• W3048587704 creator A5041982510 @default.
• W3048587704 creator A5043490198 @default.
• W3048587704 creator A5048983251 @default.
• W3048587704 creator A5056749846 @default.
• W3048587704 creator A5061888144 @default.
• W3048587704 creator A5063837076 @default.
• W3048587704 creator A5075720582 @default.
• W3048587704 creator A5078651083 @default.
• W3048587704 creator A5080630656 @default.
• W3048587704 creator A5083785482 @default.
• W3048587704 date "2020-09-01" @default.
• W3048587704 modified "2023-10-14" @default.
• W3048587704 title "A novel screening approach comparing kinase activity of small molecule inhibitors with similar molecular structures and distinct biologic effects in triple-negative breast cancer to identify targetable signaling pathways" @default.
• W3048587704 cites W1894583996 @default.
• W3048587704 cites W1918079945 @default.
• W3048587704 cites W1966285532 @default.
• W3048587704 cites W1974208182 @default.
• W3048587704 cites W1986329074 @default.
• W3048587704 cites W1992791258 @default.
• W3048587704 cites W1993188287 @default.
• W3048587704 cites W2011420281 @default.
• W3048587704 cites W2014428158 @default.
• W3048587704 cites W2015270439 @default.
• W3048587704 cites W2026260372 @default.
• W3048587704 cites W2058727957 @default.
• W3048587704 cites W2060797544 @default.
• W3048587704 cites W2062648563 @default.
• W3048587704 cites W2077810031 @default.
• W3048587704 cites W2096027508 @default.
• W3048587704 cites W2096963663 @default.
• W3048587704 cites W2113207478 @default.
• W3048587704 cites W2113247673 @default.
• W3048587704 cites W2114496204 @default.
• W3048587704 cites W2131554707 @default.
• W3048587704 cites W2134066291 @default.
• W3048587704 cites W2152265294 @default.
• W3048587704 cites W2152803331 @default.
• W3048587704 cites W2157177751 @default.
• W3048587704 cites W2163444608 @default.
• W3048587704 cites W2276336416 @default.
• W3048587704 cites W2558366645 @default.
• W3048587704 cites W2586337333 @default.
• W3048587704 cites W2742309029 @default.
• W3048587704 cites W2746672093 @default.
• W3048587704 cites W2770511852 @default.
• W3048587704 cites W2781525129 @default.
• W3048587704 cites W2787551631 @default.
• W3048587704 cites W2788735115 @default.
• W3048587704 cites W2794018125 @default.
• W3048587704 cites W2794930605 @default.
• W3048587704 cites W2797274877 @default.
• W3048587704 cites W2806897942 @default.
• W3048587704 cites W2886485146 @default.
• W3048587704 cites W2978126835 @default.
• W3048587704 doi "https://doi.org/10.1097/cad.0000000000000962" @default.
• W3048587704 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8092417" @default.
• W3048587704 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32796402" @default.
• W3048587704 hasPublicationYear "2020" @default.
• W3048587704 type Work @default.
• W3048587704 sameAs 3048587704 @default.
• W3048587704 citedByCount "0" @default.
• W3048587704 crossrefType "journal-article" @default.
• W3048587704 hasAuthorship W3048587704A5006697336 @default.
• W3048587704 hasAuthorship W3048587704A5010254355 @default.
• W3048587704 hasAuthorship W3048587704A5010293836 @default.
• W3048587704 hasAuthorship W3048587704A5017494236 @default.
• W3048587704 hasAuthorship W3048587704A5017610194 @default.
• W3048587704 hasAuthorship W3048587704A5029131894 @default.
• W3048587704 hasAuthorship W3048587704A5030154591 @default.
• W3048587704 hasAuthorship W3048587704A5030449403 @default.
• W3048587704 hasAuthorship W3048587704A5034349178 @default.
• W3048587704 hasAuthorship W3048587704A5038821469 @default.
• W3048587704 hasAuthorship W3048587704A5040817295 @default.
• W3048587704 hasAuthorship W3048587704A5041222618 @default.
• W3048587704 hasAuthorship W3048587704A5041301571 @default.
• W3048587704 hasAuthorship W3048587704A5041982510 @default.
• W3048587704 hasAuthorship W3048587704A5043490198 @default.
• W3048587704 hasAuthorship W3048587704A5048983251 @default.
• W3048587704 hasAuthorship W3048587704A5056749846 @default.
• W3048587704 hasAuthorship W3048587704A5061888144 @default.
• W3048587704 hasAuthorship W3048587704A5063837076 @default.
• W3048587704 hasAuthorship W3048587704A5075720582 @default.
• W3048587704 hasAuthorship W3048587704A5078651083 @default.

• next